Cipla Health Ltd Revenue and Competitors
Employee Data
- Cipla Health Ltd has 1248 Employees.
- Cipla Health Ltd grew their employee count by 12% last year.
Cipla Health Ltd's People
Name | Title | Email/Phone |
---|
What Is Cipla Health Ltd?
Cipla Health Ltd. offers a folio of diverse brands, distilled out of innovation and the desire to help consumers attain a state of well being. Nicotex, Cofsils, ActivKids, Prolyte ORS, Mamaxpert, and Maxirich are some of our state-of-the-art products that are aimed at not only the betterment of health but also lifestyle enhancement. With innovation at the fore, Cipla Health started the journey of independent consumer healthcare brand in 2015 and launched brands and products based on thorough market research, driving the company's growth through their individual USPs, and a focus on the end goal - to build a healthy and strong future for the Indian consumers. Â As a research-driven and fast-paced start-up, we continuously strive to stay ahead and contribute to the on-going need for quality healthcare and an improved lifestyle with our wellness range trusted by the consumers.
keywords:N/AN/A
Total Funding
1248
Number of Employees
N/A
Revenue (est)
12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Cipla Health Ltd News
... Cipla (India), Sante Verte Lab (France), Sandoz International GmbH (Germany), Biocon Ltd (India), Dr. Reddy's Laboratories (India), Wright Health Group...
... Merck Sharp & Dohme Corp., Novartis AG, Cipla Inc., GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company,...
... Hetero labs Ltd., Cipla Ltd., Cadila healthcare Ltd., Ipca laboratories ... As mentioned by the World Health Organization, it was first...
Drug major Cipla on Saturday said its shareholders have approved a proposal to raise up to Rs 3,000 crore through issuance of equity shares or other securities convertible into equity shares. The move was approved by Cipla’s Board in May 2019. In a regulatory filing, Cipla said 99.68 per cent s ...
With this acquisition, Cipla will have more relevance to wholesale and retail customers Pharmaceutical firm Cipla today announced that its UK arm, Cipla (EU) has closed the USD 550 million deal to acquire two US-based firms, InvaGen Pharmaceuticals and Exelan Pharmaceuticals. The acquisition w ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $180.1M | 1255 | 16% | N/A |
#2 | $127.5M | 1256 | 7% | N/A |
#3 | $1.7M | 1261 | 56% | N/A |
#4 | $200.7M | 1263 | -5% | N/A |
#5 | N/A | 1269 | 2% | N/A |